Search research articles
Contact Us
Filters
Showing results (31-40 of 85) with videos related to
Page
of 9
Sort By:
British Journal of Cancer
|
October 17, 2003
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer
F Graziano, D Santini, E Testa, et al.
Anticancer Research
|
January 18, 2003
A new cisplatin/gemcitabine schedule in locally advanced (IIIB) and metastatic (IV) non-small cell lung cancer: relationship between dose-intensity and efficacy. A phase II study
D Rossi, F Graziano, V Catalano, et al.
BMC Cancer
|
August 24, 2001
Potential role and chronology of abnormal expression of the Deleted in Colon Cancer (DCC) and the p53 proteins in the development of gastric cancer
F Graziano, S Cascinu, M P Staccioli, et al.
Immunopharmacology and Immunotoxicology
|
April 5, 2005
Thymidine phosphorylase profiles in nonmalignant and malignant pancreatic tissue. Potential therapeutic role of capecitabine on tumoral and endothelial cells and tumor-infiltrating macrophages
L Passantino, R Patruno, P Valerio, et al.
British Journal of Cancer
|
March 17, 2005
Over-DI dissection may question the value of radiotherapy as a part of an adjuvant programme in high-risk radically resected gastric cancer patients
M Scartozzi, E Galizia, F Graziano, et al.
Anticancer Research
|
March 28, 2001
Prognostic value of S-phase fraction in T3N0M0 gastric cancer. Implications for adjuvant chemotherapy
S Cascinu, F Graziano, V Catalano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 1999
Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil
S Cascinu, C Aschele, S Barni, et al.
Oncology
|
July 15, 2005
The role of 5-fluorouracil (5-FU) reintroduction with irinotecan or oxaliplatin in truly 5-FU-refractory advanced colorectal cancer patients
M Scartozzi, A Sobrero, G Gasparini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2001
Vascular endothelial growth factor expression, S-phase fraction and thymidylate synthase quantitation in node-positive colon cancer: relationships with tumor recurrence and resistance to adjuvant chemotherapy
S Cascinu, F Graziano, M Valentini, et al.
World Journal of Oncology
|
November 18, 2017
"Short Course" of Nonpegylated Liposomal Doxorubicin Plus Paclitaxel and Trastuzumb as Primary Systemic Therapy for Operable and Locally-Advanced Breast Cancer: A Phase II Study (PacLiDox 07)
D Rossi, B Pistilli, D Morale, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 85) with videos related to
Sort By:
Page
of 9
British Journal of Cancer
|
October 17, 2003
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer
F Graziano, D Santini, E Testa, et al.
Anticancer Research
|
January 18, 2003
A new cisplatin/gemcitabine schedule in locally advanced (IIIB) and metastatic (IV) non-small cell lung cancer: relationship between dose-intensity and efficacy. A phase II study
D Rossi, F Graziano, V Catalano, et al.
BMC Cancer
|
August 24, 2001
Potential role and chronology of abnormal expression of the Deleted in Colon Cancer (DCC) and the p53 proteins in the development of gastric cancer
F Graziano, S Cascinu, M P Staccioli, et al.
Immunopharmacology and Immunotoxicology
|
April 5, 2005
Thymidine phosphorylase profiles in nonmalignant and malignant pancreatic tissue. Potential therapeutic role of capecitabine on tumoral and endothelial cells and tumor-infiltrating macrophages
L Passantino, R Patruno, P Valerio, et al.
British Journal of Cancer
|
March 17, 2005
Over-DI dissection may question the value of radiotherapy as a part of an adjuvant programme in high-risk radically resected gastric cancer patients
M Scartozzi, E Galizia, F Graziano, et al.
Anticancer Research
|
March 28, 2001
Prognostic value of S-phase fraction in T3N0M0 gastric cancer. Implications for adjuvant chemotherapy
S Cascinu, F Graziano, V Catalano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 1999
Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil
S Cascinu, C Aschele, S Barni, et al.
Oncology
|
July 15, 2005
The role of 5-fluorouracil (5-FU) reintroduction with irinotecan or oxaliplatin in truly 5-FU-refractory advanced colorectal cancer patients
M Scartozzi, A Sobrero, G Gasparini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2001
Vascular endothelial growth factor expression, S-phase fraction and thymidylate synthase quantitation in node-positive colon cancer: relationships with tumor recurrence and resistance to adjuvant chemotherapy
S Cascinu, F Graziano, M Valentini, et al.
World Journal of Oncology
|
November 18, 2017
"Short Course" of Nonpegylated Liposomal Doxorubicin Plus Paclitaxel and Trastuzumb as Primary Systemic Therapy for Operable and Locally-Advanced Breast Cancer: A Phase II Study (PacLiDox 07)
D Rossi, B Pistilli, D Morale, et al.
Page
of 9